Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence

Clinical trial NCT03197155 · COMPLETED

Trial details

NCT number: NCT03197155
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Hepatitis C Direct Acting Antivirals

Start date: 2016-06-01
Primary completion: 2017-01-31
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.